These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. DDR2/STAT3 Positive Feedback Loop Mediates the Immunosuppressive Microenvironment by Upregulating PD-L1 and Recruiting MDSCs in Oxaliplatin-Resistant HCC. Liu W; Zhang F; Quan B; Yao F; Chen R; Ren Z; Dong L; Yin X Cell Mol Gastroenterol Hepatol; 2024; 18(4):101377. PubMed ID: 38969205 [TBL] [Abstract][Full Text] [Related]
4. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy. Zhou J; Liu M; Sun H; Feng Y; Xu L; Chan AWH; Tong JH; Wong J; Chong CCN; Lai PBS; Wang HK; Tsang SW; Goodwin T; Liu R; Huang L; Chen Z; Sung JJ; Chow KL; To KF; Cheng AS Gut; 2018 May; 67(5):931-944. PubMed ID: 28939663 [TBL] [Abstract][Full Text] [Related]
5. Endoplasmic reticulum stress induced LOX-1 Nan J; Xing YF; Hu B; Tang JX; Dong HM; He YM; Ruan DY; Ye QJ; Cai JR; Ma XK; Chen J; Cai XR; Lin ZX; Wu XY; Li X Immunology; 2018 May; 154(1):144-155. PubMed ID: 29211299 [TBL] [Abstract][Full Text] [Related]
6. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862 [TBL] [Abstract][Full Text] [Related]
7. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma. Yokota S; Yonezawa T; Momoi Y; Maeda S Vet Immunol Immunopathol; 2024 Mar; 269():110716. PubMed ID: 38308864 [TBL] [Abstract][Full Text] [Related]
8. CD205 Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883 [TBL] [Abstract][Full Text] [Related]
9. Size-Tunable Nanoregulator-Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular Carcinoma. Tang Y; Shu Z; Zhu M; Li S; Ling Y; Fu Y; Hu Z; Wang J; Yang Z; Liao J; Xu L; Yu M; Peng Z Adv Healthc Mater; 2023 Dec; 12(30):e2302013. PubMed ID: 37665720 [TBL] [Abstract][Full Text] [Related]
10. Letter to the Editor: Is eliminating METTL1-mediated accumulation of PMN-MDSCs sufficient to prevent hepatocellular carcinoma recurrence after radiofrequency ablation? Yang F; Jiang S; Zheng Y Hepatology; 2023 Apr; 77(4):E62-E63. PubMed ID: 35753066 [No Abstract] [Full Text] [Related]
11. Visualization and quantification of Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525 [TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment. Zhang F; Hu K; Liu W; Quan B; Li M; Lu S; Chen R; Ren Z; Yin X Cell Mol Gastroenterol Hepatol; 2023; 15(3):573-591. PubMed ID: 36513250 [TBL] [Abstract][Full Text] [Related]
13. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils. Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638 [TBL] [Abstract][Full Text] [Related]
14. ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer. Chen H; Yang K; Pang L; Fei J; Zhu Y; Zhou J J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822671 [TBL] [Abstract][Full Text] [Related]
15. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation. Shi ZR; Duan YX; Cui F; Wu ZJ; Li MP; Song PP; Peng QL; Ye WT; Yin KL; Kang MQ; Yu YX; Yang J; Tang W; Liao R J Exp Clin Cancer Res; 2023 May; 42(1):133. PubMed ID: 37231509 [TBL] [Abstract][Full Text] [Related]
16. Targeting tumour-intrinsic N Liu H; Zeng X; Ren X; Zhang Y; Huang M; Tan L; Dai Z; Lai J; Xie W; Chen Z; Peng S; Xu L; Chen S; Shen S; Kuang M; Lin S Gut; 2023 Aug; 72(8):1555-1567. PubMed ID: 36283801 [TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinoma. Sun T; Sun B; Cao Y; Liu J; Chen J; Liang B; Zheng C; Kan X Biomed Pharmacother; 2023 Oct; 166():115351. PubMed ID: 37625323 [TBL] [Abstract][Full Text] [Related]
18. PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma. Liu X; Liu M; Wu H; Tang W; Yang W; Chan TTH; Zhang L; Chen S; Xiong Z; Liang J; Wai-Yiu Si-Tou W; Shu T; Li J; Cao J; Zhong C; Sun H; Kwong TT; Leung HHW; Wong J; Bo-San Lai P; To KF; Xiang T; Jao-Yiu Sung J; Chan SL; Zhou J; Sze-Lok Cheng A JHEP Rep; 2024 Jul; 6(7):101087. PubMed ID: 38882672 [TBL] [Abstract][Full Text] [Related]
19. Identification and validation of Birc5 as a novel activated cell cycle program biomarker associated with infiltration of immunosuppressive myeloid-derived suppressor cells in hepatocellular carcinoma. Liu Y; Chen X; Luo W; Zhao Y; Nashan B; Huang L; Yuan X Cancer Med; 2023 Aug; 12(15):16370-16385. PubMed ID: 37326143 [TBL] [Abstract][Full Text] [Related]
20. Role of Myeloid-Derived Suppressor Cells in High-Dose-Irradiated TRAMP-C1 Tumors: A Therapeutic Target and an Index for Assessing Tumor Microenvironment. Fu SY; Chen FH; Wang CC; Yu CF; Chiang CS; Hong JH Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1547-1558. PubMed ID: 33188861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]